Depression and increased myocardial ischemic activity in patients with ischemic heart disease

Wei Jiang1, Michael A Babyak, Alan Rozanski

  • 1Departments of Department ofPsychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. jiang001@mc.duke.edu

Insights

Depression in ischemic heart disease (IHD) patients is linked to myocardial ischemia. Mild to moderate depressive symptoms increase the likelihood of ischemia during stress and daily life, potentially explaining IHD outcomes.

Area of Science:

  • Cardiology
  • Psychiatry
  • Psychosomatic Medicine

Background:

  • Depression is common in patients with ischemic heart disease (IHD).
  • The mechanisms linking depression to adverse IHD outcomes are unclear.
  • This study investigated depression's impact on myocardial ischemia in IHD patients.

Purpose of the Study:

  • To examine the relationship between depressive symptoms and myocardial ischemia.
  • To assess ischemia during mental stress and daily living in stable IHD patients.

Main Methods:

  • 135 IHD patients completed the Center for Epidemiological Studies-Depression (CES-D) scale.
  • Radionuclide ventriculography assessed left ventricular wall motion abnormality during stress.
  • 48-hour ambulatory ECG monitored myocardial ischemia during daily life.

Main Results:

  • A curvilinear relationship was found between CES-D scores and ischemia probability.
  • CES-D scores ≤19 were associated with a 2-fold increased likelihood of ischemia during mental stress.
  • Similar patterns were observed for ischemia during daily living.

Conclusions:

  • Mild to moderate depressive symptoms (CES-D ≤19) correlate with increased myocardial ischemia.
  • Myocardial ischemia may mediate depression's negative impact on IHD outcomes.
  • Further research is needed to explore the inverse association at higher depression levels.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...